• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1例使用克拉霉素治疗的滤泡性B细胞淋巴瘤病例。

A case of follicular B-cell lymphoma treated using clarithromycin.

作者信息

Ohe Masashi, Hashino Satoshi

机构信息

Department of General Medicine, Hokkaido Social Insurance Hospital, Sapporo, Japan.

出版信息

Korean J Hematol. 2011 Sep;46(3):203-6. doi: 10.5045/kjh.2011.46.3.203. Epub 2011 Sep 30.

DOI:10.5045/kjh.2011.46.3.203
PMID:22065978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3208206/
Abstract

We report a case of follicular B-cell lymphoma (FL) treated successfully using clarithromycin (CAM). A 44-year-old man who presented with lymphadenopathy was diagnosed with FL after a histological examination of his biopsy specimens. He was administered chemotherapy with R-CHOP (rituximab, cyclophosphamide, adriamycin, vincristine, and prednisolone) following which stable disease was achieved. However, the subsequent clinical course showed partial remission of FL and stable disease with tumor regrowth, each of which was treated with chemotherapeutic regimens. Since the patient was diagnosed with leukocytopenia, he could not undergo chemotherapy for the third regrowth; hence, he was administered CAM. His lymphadenopathy regressed and the levels of soluble interleukin 2-receptor decreased. This case shows that treatment using CAM may be effective in some cases of FL.

摘要

我们报告了一例使用克拉霉素(CAM)成功治疗的滤泡性B细胞淋巴瘤(FL)病例。一名44岁出现淋巴结病的男性在对其活检标本进行组织学检查后被诊断为FL。他接受了R-CHOP(利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松龙)化疗,随后病情稳定。然而,随后的临床病程显示FL部分缓解且病情稳定,但肿瘤有复发,每次复发均采用化疗方案治疗。由于该患者被诊断为白细胞减少症,第三次复发时无法进行化疗;因此,给他使用了CAM。他的淋巴结病消退,可溶性白细胞介素2受体水平下降。该病例表明,在某些FL病例中,使用CAM治疗可能有效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/a30a416cfdbe/kjh-46-203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/3aa85ee2798f/kjh-46-203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/f30ccf6e89dd/kjh-46-203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/a30a416cfdbe/kjh-46-203-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/3aa85ee2798f/kjh-46-203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/f30ccf6e89dd/kjh-46-203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a572/3208206/a30a416cfdbe/kjh-46-203-g003.jpg

相似文献

1
A case of follicular B-cell lymphoma treated using clarithromycin.1例使用克拉霉素治疗的滤泡性B细胞淋巴瘤病例。
Korean J Hematol. 2011 Sep;46(3):203-6. doi: 10.5045/kjh.2011.46.3.203. Epub 2011 Sep 30.
2
[Follicular lymphoma: first - line selection criteria of treatment].[滤泡性淋巴瘤:一线治疗选择标准]
Ter Arkh. 2019 Aug 15;91(8):75-83. doi: 10.26442/00403660.2019.08.000388.
3
Rituximab for the first-line treatment of stage III-IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation.利妥昔单抗作为 III-IV 期滤泡性淋巴瘤的一线治疗药物(对技术评估第 110 号的回顾):一项系统评价和经济评估。
Health Technol Assess. 2012;16(37):1-253, iii-iv. doi: 10.3310/hta16370.
4
Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study.苯达莫司汀联合利妥昔单抗对比 R-CHOP 一线治疗 3A 级滤泡性淋巴瘤患者:一项多中心回顾性研究的证据。
Oncologist. 2018 Apr;23(4):454-460. doi: 10.1634/theoncologist.2017-0037. Epub 2018 Jan 9.
5
A unique composite follicular lymphoma and mantle cell lymphoma with a mixed cell pattern and aggressive course.一种独特的复合滤泡性淋巴瘤和套细胞淋巴瘤,具有混合细胞形态和侵袭性病程。
Am J Clin Pathol. 2014 May;141(5):737-41. doi: 10.1309/AJCPAWDDYO5OQYCD.
6
Assessing the Effectiveness of Treatment Sequences for Older Patients With High-risk Follicular Lymphoma With a Multistate Model.使用多状态模型评估高危滤泡性淋巴瘤老年患者治疗序列的有效性。
Clin Lymphoma Myeloma Leuk. 2019 May;19(5):300-309.e5. doi: 10.1016/j.clml.2018.12.019. Epub 2019 Jan 3.
7
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.一线 R-CVP 与 R-CHOP 诱导免疫化疗联合利妥昔单抗维持治疗惰性淋巴瘤的多中心 III 期随机研究。由波兰淋巴瘤研究小组(PLRG4)进行。
Br J Haematol. 2020 Mar;188(6):898-906. doi: 10.1111/bjh.16264. Epub 2019 Dec 2.
8
Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.利妥昔单抗联合CHOP化疗治疗低度或滤泡性非霍奇金淋巴瘤患者的长期临床和分子缓解:9年随访
J Clin Oncol. 2004 Dec 1;22(23):4711-6. doi: 10.1200/JCO.2004.04.020. Epub 2004 Oct 13.
9
Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.克拉霉素和泼尼松龙成功治疗弥漫性大B细胞淋巴瘤。
Korean J Hematol. 2012 Dec;47(4):293-7. doi: 10.5045/kjh.2012.47.4.293. Epub 2012 Dec 24.
10
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.与单纯使用环磷酰胺、阿霉素、长春新碱和泼尼松(CHOP)方案治疗相比,在CHOP方案基础上加用利妥昔单抗进行一线治疗可显著改善晚期滤泡性淋巴瘤患者的预后:德国低度淋巴瘤研究组的一项前瞻性随机研究结果。
Blood. 2005 Dec 1;106(12):3725-32. doi: 10.1182/blood-2005-01-0016. Epub 2005 Aug 25.

引用本文的文献

1
Possible mechanisms of action of clarithromycin and its clinical application as a repurposing drug for treating multiple myeloma.克拉霉素的可能作用机制及其作为治疗多发性骨髓瘤的重新利用药物的临床应用。
Ecancermedicalscience. 2020 Aug 18;14:1088. doi: 10.3332/ecancer.2020.1088. eCollection 2020.
2
A case of Waldenström's macroglobulinemia treated using clarithromycin and prednisolone.一例使用克拉霉素和泼尼松龙治疗的华氏巨球蛋白血症病例。
Transl Clin Pharmacol. 2017 Sep;25(3):134-137. doi: 10.12793/tcp.2017.25.3.134. Epub 2017 Sep 15.
3
Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin.

本文引用的文献

1
Partial regression of duodenal lesions of intestinal follicular lymphoma after antibiotic treatment.抗生素治疗后肠滤泡性淋巴瘤的十二指肠病变部分消退。
Dig Endosc. 2010 Oct;22(4):316-8. doi: 10.1111/j.1443-1661.2010.01011.x.
2
Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin.两例肺黏膜相关淋巴组织淋巴瘤患者经克拉霉素成功治疗。
Chest. 2010 Sep;138(3):730-3. doi: 10.1378/chest.09-2358.
3
Six-month oral clarithromycin regimen is safe and active in extranodal marginal zone B-cell lymphomas: final results of a single-centre phase II trial.
克拉霉素成功治疗血管免疫母细胞性T细胞淋巴瘤
Blood Res. 2016 Jun;51(2):139-42. doi: 10.5045/br.2016.51.2.139. Epub 2016 Jun 23.
4
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent.肿瘤学中药物的重新利用(ReDO)——克拉霉素作为一种抗癌药物。
Ecancermedicalscience. 2015 Feb 24;9:513. doi: 10.3332/ecancer.2015.513. eCollection 2015.
5
Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide.克拉霉素、泼尼松龙和环磷酰胺成功治疗复发性滤泡性B细胞淋巴瘤。
Korean J Intern Med. 2013 May;28(3):377-9. doi: 10.3904/kjim.2013.28.3.377. Epub 2013 May 1.
6
Successful treatment of diffuse large B-cell lymphoma with clarithromycin and prednisolone.克拉霉素和泼尼松龙成功治疗弥漫性大B细胞淋巴瘤。
Korean J Hematol. 2012 Dec;47(4):293-7. doi: 10.5045/kjh.2012.47.4.293. Epub 2012 Dec 24.
六个月口服克拉霉素方案治疗结外边缘区B细胞淋巴瘤安全且有效:一项单中心II期试验的最终结果
Br J Haematol. 2010 Jul;150(2):226-9. doi: 10.1111/j.1365-2141.2010.08179.x. Epub 2010 Apr 28.
4
Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells.雷帕霉素和姜黄素可诱导原发性静止B慢性淋巴细胞白血病细胞凋亡。
Leuk Lymphoma. 2009 Apr;50(4):625-32. doi: 10.1080/10428190902789181.
5
BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.BiRD(克拉仙[克拉霉素]/瑞复美[来那度胺]/地塞米松)联合疗法在初治有症状的多发性骨髓瘤患者中产生了较高的完全缓解率和总缓解率。
Blood. 2008 Feb 1;111(3):1101-9. doi: 10.1182/blood-2007-05-090258. Epub 2007 Nov 7.
6
Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma.滤泡性淋巴瘤转化为弥漫性大B细胞淋巴瘤的风险及临床意义。
J Clin Oncol. 2007 Jun 10;25(17):2426-33. doi: 10.1200/JCO.2006.09.3260. Epub 2007 May 7.
7
Antibiotics directly induce apoptosis in B cell lymphoma cells derived from BALB/c mice.抗生素可直接诱导源自BALB/c小鼠的B细胞淋巴瘤细胞发生凋亡。
Anticancer Res. 2004 Nov-Dec;24(6):3723-30.
8
Clarithromycin and azithromycin induce apoptosis of activated lymphocytes via down-regulation of Bcl-xL.克拉霉素和阿奇霉素通过下调Bcl-xL诱导活化淋巴细胞凋亡。
Int Immunopharmacol. 2004 Sep;4(9):1201-7. doi: 10.1016/j.intimp.2004.05.011.
9
Follicular lymphoma international prognostic index.滤泡性淋巴瘤国际预后指数
Blood. 2004 Sep 1;104(5):1258-65. doi: 10.1182/blood-2003-12-4434. Epub 2004 May 4.
10
Prognostic significance of bcl-xL gene expression and apoptotic cell counts in follicular lymphoma.
Blood. 2004 Jan 15;103(2):695-7. doi: 10.1182/blood-2003-06-1901. Epub 2003 Sep 11.